Impact of human papillomavirus vaccine on cervical cancer epidemic: Evidence from the surveillance, epidemiology, and end results program

Impact of human papillomavirus vaccine on cervical cancer epidemic: Evidence from the surveillance, epidemiology, and end results program

IntroductionSince 2006, the human papillomavirus (HPV) vaccine has been recommended for females aged 9–26 years in the United States. Aiming to evaluate the early effect of the HPV vaccine on cervical cancer, this study assessed the incidence of cervical cancer by age and histology before and after...

Full description

Bibliographic Details
Main Authors: Jiao Pei, Ting Shu, Chenyao Wu, Mandi Li, Minghan Xu, Min Jiang, Cairong Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Public Health
Subjects:
HPV vaccine
cervical cancer
incidence
projection
vaccine impact
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.998174/full

Similar Items

Similar Items